4.7 Article

Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting ß-catenin nuclear translocation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

RAPGEF5 Regulates Nuclear Translocation of β-Catenin

John N. Griffin et al.

DEVELOPMENTAL CELL (2018)

Review Oncology

Clinical relevance of colorectal cancer molecular subtypes

Nuria Rodriguez-Salas et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Oncology

Colorectal cancer statistics, 2014

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2014)

Article Biochemistry & Molecular Biology

LIM kinase-2 induces programmed necrotic neuronal death via dysfunction of DRP1-mediated mitochondrial fission

J-E Kim et al.

CELL DEATH AND DIFFERENTIATION (2014)

Article Biochemistry & Molecular Biology

LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2

A. Petrilli et al.

ONCOGENE (2014)

Article Cell Biology

LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy

Emmanuel O. Johnson et al.

JOURNAL OF CELL SCIENCE (2012)

Article Medicine, General & Internal

Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

Ann G. Zauber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

Keratinocyte Migration in the Developing Eyelid Requires LIMK2

Dennis S. Rice et al.

PLOS ONE (2012)

Review Oncology

Molecular networks that regulate cancer metastasis

Daniela Spano et al.

SEMINARS IN CANCER BIOLOGY (2012)

Article Pathology

Update on the serrated pathway to colorectal carcinoma

Dale C. Snover

HUMAN PATHOLOGY (2011)

Editorial Material Pathology

The serrated polyp: getting it right!

A. Ensari et al.

JOURNAL OF CLINICAL PATHOLOGY (2010)

Review Oncology

The molecular pathology of cancer

Timothy J. R. Harris et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2010)